Rapid, reversible impairment of synaptic signaling in cultured cortical neurons by exogenously-applied amyloid-β

Journal of Alzheimer's Disease

Volumn 35, Issue 2, 2013, Pages 395-402

  Lee, Sangmook ^a   Zemianek, Jill ^a   Shea, Thomas B ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

Amyloid ; calcium; cortical neurons; culture; synaptic signaling

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM; DIZOCILPINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; NIMODIPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; COGNITION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84877110578     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122452     Document Type: Article

References (51)

1. Finder VH (2010) Alzheimer's disease: A general introduction and pathomechanism. J Alzheimers Dis 22(Suppl 3), 5-19.
2. Rowan MJ, Klyubin I, Wang Q, Anwyl R (2005) Synaptic plasticity disruption by amyloid beta protein: Modulation by potential Alzheimer's disease modifying therapies. Biochem Soc Trans 33, 563-567.
3. Innocent N, Evans N, Hille C,Wonnacott S (2010) Oligomerisation differentially affects the acute and chronic actions of amyloid-beta in vitro. Neuropharmacology 59, 343-352.
4. Larson ME, Lesne SE (2012) Soluble Abeta oligomer production and toxicity. J Neurochem 120(Suppl 1), 125-139.
5. Ekinci FJ, Linsley MD, Shea TB (2000) Beta-Amyloidinduced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation. Brain Res Mol Brain Res 76, 389-395.
6. Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC (2012) Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-Aspartate receptors in cortical cultures. Cell Calcium 51, 95-106.
7. Lilja AM, Porras O, Storelli E, NordbergA, MarutleA(2011) Functional interactions of fibrillar and oligomeric amyloidbeta with alpha7 nicotinic receptors in Alzheimer's disease. J Alzheimers Dis 23, 335-347.
8. Ekinci FJ, Malik KU, Shea TB (1999) Activation of the L voltage-sensitive calcium channel by mitogen-Activated protein (MAP) kinase following exposure of neuronal cells to beta-Amyloid. MAP kinase mediates beta-Amyloid-induced neurodegeneration. J Biol Chem 274, 30322-30327.
9. Ho PI, Collins SC, Dhitavat S, Ortiz D, Ashline D, Rogers E, Shea TB (2001) Homocysteine potentiates beta-Amyloid neurotoxicity: Role of oxidative stress. J Neurochem 78, 249-253.
10. Shabala L, Howells C,West AK, Chung RS (2010) Prolonged Abeta treatment leads to impairment in the ability of primary cortical neurons to maintain K+ and Ca2+ homeostasis. Mol Neurodegener 5, 30.
11. Strozyk D, Launer LJ, Adlard PA, Cherny RA, Tsatsanis A, Volitakis I, Blennow K, Petrovitch H, White LR, Bush AI (2009) Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol Aging 30, 1069-1077.
12. White AR, Huang X, Jobling MF, Barrow CJ, Beyreuther K, Masters CL, Bush AI, Cappai R (2001) Homocysteine potentiates copper-And amyloid beta peptide-mediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimer's-Type neurodegenerative pathways. J Neurochem 76, 1509-1520.
13. Alzoubi KH, Alhaider IA, Tran TT, Mosely A, Alkadhi KK (2011) Impaired neural transmission and synaptic plasticity in superior cervical ganglia from beta-Amyloid rat model of Alzheimer's disease. Curr Alzheimer Res 8, 377-384.
14. Balleza-Tapia H, Huanosta-Gutierrez A, Marquez-Ramos A, Arias N, Pena F (2010) Amyloid beta oligomers decrease hippocampal spontaneous network activity in an age-dependent manner. Curr Alzheimer Res 7, 453-462.
15. Kittelberger KA, Piazza F, Tesco G, Reijmers LG (2012) Natural amyloid-beta oligomers acutely impair the formation of a contextual fear memory in mice. PLoS One 7, e29940.
16. Koffie RM, Hyman BT, Spires-Jones TL (2011) Alzheimer's disease: Synapses gone cold. Mol Neurodegener 6, 63.
17. Nimmrich V, Ebert U (2009) Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-Amyloid. Rev Neurosci 20, 1-12.
18. Parihar MS, Brewer GJ (2010) Amyloid-beta as a modulator of synaptic plasticity. J Alzheimers Dis 22, 741-763.
19. Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ (2006) Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: A potent role for trimers. J Physiol 572, 477-492.
20. Turner PR, O'Connor K, TateWP, AbrahamWC(2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol 70, 1-32.
21. Wasling P, Daborg J, Riebe I, Andersson M, Portelius E, Blennow K, Hanse E, Zetterberg H (2009) Synaptic retrogenesis and amyloid-beta in Alzheimer's disease. J Alzheimers Dis 16, 1-14.
22. Sivanesan S, Tan A, Rajadas J (2012) Pathogenesis of Abeta oligomers in synaptic failure. Curr Alzheimer Res. doi: CAREPUB-20121002-2.
23. Budson AE, Solomon PR (2012) New criteria for Alzheimer disease and mild cognitive impairment: Implications for the practicing clinician. Neurologist 18, 356-363.
24. Zemianek JM, Serra M, Guaraldi M, Shea TB (2012) Stimulation with a low-Amplitude, digitized synaptic signal to invoke robust activity within neuronal networks on multielectrode arrays. BioTechniques 52, 177-182.
25. Bolton MM, Eroglu C (2009) Look who is weaving the neural web: Glial control of synapse formation. Curr Opin Neurobiol 19, 491-497.
26. Serra M, Guaraldi M, Shea TB (2010) Inhibitory neurons modulate spontaneous signaling in cultured cortical neurons: Density-dependent regulation of excitatory neuronal signaling. Phys Bior 7, 026009.
27. Zemianek JM, Lee S, Guaraldi M, Shea TB (2012) Accelerated establishment of mature signaling patterns following stimulation of developing neuronal networks: "learning" versus "plasticity". Int J Dev Neurosci 30, 602-606.
28. Klug GM, Losic D, Subasinghe SS, Aguilar MI, Martin LL, Small DH (2003) Beta-Amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH. Eur J Biochem 270, 4282-4293.
29. Prangkio P, Yusko EC, Sept D, Yang J, Mayer M (2012) Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity. PLoS One 7, e47261.
30. Lee S, Lemere CA, Frost JL, Shea TB (2012) Dietary supplementation with S-Adenosyl methionine delayed amyloid-beta and tau pathology in 3xTg-AD mice. J Alzheimers Dis 28, 423-431.
31. Ho R, Ortiz D, Shea TB (2001) Amyloid-beta promotes calcium influx and neurodegeneration via stimulation of L voltage-sensitive calcium channels rather than NMDA channels in cultured neurons. J Alzheimers Dis 3, 479-483.
32. Lee WS, Tsai WJ, Yeh PH,Wei BL, Chiou WF (2006) Divergent role of calcium on Abeta-And MPTP-induced cell death in SK-N-SH neuroblastoma. Life Sci 78, 1268-1275.
33. Wagenaar DA, Madhavan R, Pine J, Potter SM (2005) ontrolling bursting in cortical cultures with closed-loop multi-electrode stimulation. J Neurosci 25, 680-688.
34. Madhavan R, Chao ZC, Potter SM (2007) Plasticity of recurring spatiotemporal activity patterns in cortical networks. Phys Biol 4, 181-193.
35. Rolston JD,Wagenaar DA, Potter SM (2007) Precisely timed spatiotemporal patterns of neural activity in dissociated cortical cultures. Neuroscience 148, 294-303.
36. Wagenaar DA, Pine J, Potter SM (2006) An extremely rich repertoire of bursting patterns during the development of cortical cultures. BMC Neurosci 7, 11.
37. Zemianek JM, Lee S, Guaraldi M, Shea TB (2012) Accelerated establishment of mature signaling patterns following stimulation of developing neuronal networks: "learning" versus "plasticity". Int J Dev Neurosci 30, 602-606.
38. Mohamed A, Cortez L, de Chaves EP (2011) Aggregation state and neurotoxic properties of alzheimer beta-Amyloid peptide. Curr Protein Pept Sci 12, 235-257.
39. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, Huang X, Farrag YW, Perry G, Bush AI (2000) Evidence that the beta-Amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem 275, 19439-19442.
40. Martins IC, Kuperstein I, Wilkinson H, Maes E, Vanbrabant M, Jonckheere W, Van Gelder P, Hartmann D, D'Hooge R, De Strooper B, Schymkowitz J, Rousseau F (2008) Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J 27, 224-233.
41. Hu NW, Smith IM, Walsh DM, Rowan MJ (2008) Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo. Brain 131, 2414-2424.
42. Nunomura A, Tamaoki T, Motohashi N, Nakamura M, McKeel DW Jr, Tabaton M, Lee HG, Smith MA, Perry G, Zhu X (2012) The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominentRNAoxidation in vulnerable neurons. J Neuropathol Exp Neurol 71, 233-241.
43. Rodrigues R, Smith MA, Wang X, Perry G, Lee HG, Zhu X, Petersen RB (2012) Molecular neuropathogenesis of Alzheimer's disease: An interaction model stressing the central role of oxidative stress. Future Neurol 7, 287-305.
44. Castellani RJ, Lee HG, Perry G, Smith MA (2006) Antioxidant protection and neurodegenerative disease: The role of amyloid-beta and tau. Am J Alzheimers Dis Other Demen 21, 126-130.
45. Lopez OL, McDade E, Riverol M, Becker JT (2011) Evolution of the diagnostic criteria for degenerative and cognitive disorders. Curr Opin Neurol 24, 532-541.
46. Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, Feinberg LF, Frisoni G, Green C, Guimaraes RM, Gwyther LP, Hefti FF, Hutton M, Kawas C, Kent DM, Kuller L, Langa KM, Mahley RW, Maslow K, Masters CL, Meier DE, Neumann PJ, Paul SM, Petersen RC, Sager MA, Sano M, Schenk D, Soares H, Sperling RA, Stahl SM, van Deerlin V, Stern Y, Weir D, Wolk DA, Trojanowski JQ (2012) Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from theWare Invitational Summit. Alzheimers Dement 8, 445-452.
47. Town T (2009) Alternative Abeta immunotherapy approaches for Alzheimer's disease. CNS Neurol Disord Drug Targets 8, 114-127.
48. Kokjohn TA, Roher AE (2009) Antibody responses, amyloidbeta peptide remnants and clinical effects of AN-1792 immunization in patients with AD in an interrupted trial. CNS Neurol Disord Drug Targets 8, 88-97.
49. Spires-Jones TL, Kopeikina KJ, Koffie RM, de Calignon A, Hyman BT (2011) Are tangles as toxic as they look? J Mol Neurosci 45, 438-444.
50. Wisniewski T (2009) AD vaccines: Conclusions and future directions. CNS Neurol Disord Drug Targets 8, 160-166.
51. Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A (2012) Immunotherapy for Alzheimer's disease: From anti-beta-Amyloid to tau-based immunization strategies. Immunotherapy 4, 213-238.